Hikmet Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hikmet Yilmaz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ceyhun Kayıhan
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Baskent University, Ankara, Turkey
2 shared publications - Emre Aksoy
Department of Biological Sciences, Faculty of Arts and Sciences, Middle East Technical University, Ankara, Türkiye
2 shared publications - Halis Batuhan Ünal
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Başkent University, Ankara, Türkiye
2 shared publications - Oğuzhan Yaprak
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Baskent University, Ankara, Turkey
2 shared publications Ahmet Çağlar Özketen
1 shared publication- Aynur Karadağ Gürel
Usak University, School of Medicine
1 shared publication
Latest Publications
- Open Access
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 890-896
In silico evaluation of the role of PEA3 subfamily ETS transcription factors in chemoresistance in ovarian cancer
Background/aim: The E26 transformation-specific family of transcription factors regulates the cell cycle and apoptosis that are crucial for carcinogenesis. More specifically, the PEA3 subfamily—comprising ETS variant (ETV) transcription factors ETV1, ETV4, and ETV5—has been implicated in multiple oncogenic signaling pathways and chemotherapy resistance. While cisplatin is still a widely used chemotherapeutic treatment for ovarian cancer, its therapeutic efficacy is sometimes limited by the induction of resistance mechanisms. The present study investigates the potential role of PEA3 subfamily genes in cisplatin resistance in ovarian cancer through comprehensive in silico analyses. Materials and methods: Cisplatin response data for ovarian cancer were obtained from the Cancer Treatment Response Database version 2 (CTR-DB2), and the relevant dataset was analyzed. Candidate genes, including members of the PEA3 transcription factor subfamily, were analyzed with a multigene biomarker model, and a receiver operating characteristic analysis was used to measure predictive ability. GEPIA2, KMplotter, and cBioPortal were used for survival analysis, while the TNMplot, cBioPortal, and Clinical Proteomic Tumor Analysis Consortium datasets were used for multiomics characterization and differential expression. Results: The ETV4–CIC gene pair in the CTR-DB2 validation dataset achieved the highest predictive performance for cisplatin response in ovarian cancer with an area-under-curve of 0.939, clearly separating responders from nonresponders. No other gene combinations outperformed this model, demonstrating only moderate predictive capacity. The ETV4–CIC gene pair was also associated with disease-free survival. Differential expression analysis showed downregulation of CIC and upregulation of ETV4 in tumor tissues. Genomic and proteomic analyses confirmed alterations in both genes, while correlation analysis suggested complementary biological roles. Conclusions: The ETV4–CIC gene pair effectively discriminated between cisplatin responders and nonresponders in ovarian cancer. Accordingly, the ETV4–CIC signature may serve as a useful biomarker for cisplatin response prediction and patient stratification in precision oncology.
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 890-896
Open AccessIn silico evaluation of the role of PEA3 subfamily ETS transcription factors in chemoresistance in ovarian cancer
Background/aim: The E26 transformation-specific family of transcription factors regulates the cell cycle and apoptosis that are crucial for carcinogenesis. More specifically, the PEA3 subfamily—comprising ETS variant (ETV) transcription factors ETV1, ETV4, and ETV5—has been implicated in multiple oncogenic signaling pathways and chemotherapy resistance. While cisplatin is still a widely used chemotherapeutic treatment for ovarian cancer, its therapeutic efficacy is sometimes limited by the induction of resistance mechanisms. The present study investigates the potential role of PEA3 subfamily genes in cisplatin resistance in ovarian cancer through comprehensive in silico analyses. Materials and methods: Cisplatin response data for ovarian cancer were obtained from the Cancer Treatment Response Database version 2 (CTR-DB2), and the relevant dataset was analyzed. Candidate genes, including members of the PEA3 transcription factor subfamily, were analyzed with a multigene biomarker model, and a receiver operating characteristic analysis was used to measure predictive ability. GEPIA2, KMplotter, and cBioPortal were used for survival analysis, while the TNMplot, cBioPortal, and Clinical Proteomic Tumor Analysis Consortium datasets were used for multiomics characterization and differential expression. Results: The ETV4–CIC gene pair in the CTR-DB2 validation dataset achieved the highest predictive performance for cisplatin response in ovarian cancer with an area-under-curve of 0.939, clearly separating responders from nonresponders. No other gene combinations outperformed this model, demonstrating only moderate predictive capacity. The ETV4–CIC gene pair was also associated with disease-free survival. Differential expression analysis showed downregulation of CIC and upregulation of ETV4 in tumor tissues. Genomic and proteomic analyses confirmed alterations in both genes, while correlation analysis suggested complementary biological roles. Conclusions: The ETV4–CIC gene pair effectively discriminated between cisplatin responders and nonresponders in ovarian cancer. Accordingly, the ETV4–CIC signature may serve as a useful biomarker for cisplatin response prediction and patient stratification in precision oncology.
- 2 October 2025
- Published by Springer Nature in Plant Molecular Biology
- Vol. 115 (5) , 111
Single-cell transcriptional profiling in Arabidopsis root exposed to boron toxicity at seedling stages
- 2 October 2025
- Published by Springer Nature in Plant Molecular Biology
- Vol. 115 (5) , 111
Single-cell transcriptional profiling in Arabidopsis root exposed to boron toxicity at seedling stages
- Open Access
Single-cell transcriptional profiling in Arabidopsis root exposed to B toxicity at seedling stages
Cell-specific transcriptional responses to environmental stimuli are yet to be fully characterized in plants. In this study, we apply single-cell RNA sequencing to Arabidopsis thaliana roots exposed to boron (B) toxicity to characterize the transcription map at cellular resolution and thus, to understand how B toxicity can alter gene expression and development at single cell resolution. Single-cell transcriptomes from protoplasts of more than 2750 Arabidopsis thaliana root cells were obtained. Plotting the single-cell transcriptomes via t-SNE projections yielded six major cell clusters including quiescent cells (QC), endodermis, cortex, columella, trichoblast (root-hair), and root cap. The maximum number of most significantly upregulated genes were determined in columella under 1 mM B and in endodermis under 2 mM B condition. Additionally, the maximum number of most significantly upregulated genes under 3 mM B and 5 mM B conditions was determined in the root cap, implying a critical role against severe B toxicity conditions. We also showed that these upregulated genes are highly correlated with “glutathione metabolism” in columella and “carbon metabolism” in root cap. Taken together, for the first time in the literature, our study provides a gene expression map at single-cell resolution and describes the extent of heterogeneity at the molecular level among populations of different cell types in Arabidopsis root under B toxicity conditions.
Open AccessSingle-cell transcriptional profiling in Arabidopsis root exposed to B toxicity at seedling stages
Cell-specific transcriptional responses to environmental stimuli are yet to be fully characterized in plants. In this study, we apply single-cell RNA sequencing to Arabidopsis thaliana roots exposed to boron (B) toxicity to characterize the transcription map at cellular resolution and thus, to understand how B toxicity can alter gene expression and development at single cell resolution. Single-cell transcriptomes from protoplasts of more than 2750 Arabidopsis thaliana root cells were obtained. Plotting the single-cell transcriptomes via t-SNE projections yielded six major cell clusters including quiescent cells (QC), endodermis, cortex, columella, trichoblast (root-hair), and root cap. The maximum number of most significantly upregulated genes were determined in columella under 1 mM B and in endodermis under 2 mM B condition. Additionally, the maximum number of most significantly upregulated genes under 3 mM B and 5 mM B conditions was determined in the root cap, implying a critical role against severe B toxicity conditions. We also showed that these upregulated genes are highly correlated with “glutathione metabolism” in columella and “carbon metabolism” in root cap. Taken together, for the first time in the literature, our study provides a gene expression map at single-cell resolution and describes the extent of heterogeneity at the molecular level among populations of different cell types in Arabidopsis root under B toxicity conditions.